Default company panoramic image
Logo

Catheter Connections, Inc.

Medical device solution for IV catheter related bloodstream infections, the most deadly, costly and preventable hospital acquired infection.

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Salt Lake City, UT, USA
  • Currency USD
  • Founded June 2008
  • Employees 10
  • Website catheterconnections.com

Company Summary

CCI makes the patent protected DualCap System, which protects hospital patients from deadly IV infections. Hospitals seek device solutions as infections cost billions and there is no reimbursement. Clinical data show the DualCap System reduces infection rates. DualCap is the only FDA cleared device to disinfect BOTH IV tubing ends and catheter access sites. DualCap reduces the variability of care, improves safety, saves money and saves lives.

Team

  • Default avatar
    Guy Jordan, PhD.
    Executive Chairman

    Guy spent over 35 years in the medical industry. He was Group President at C.R. Bard with global responsibility for the oncology business and for all of Bard's R&D. Prior, he was President of Bard Access Systems where he grew the central venous access business through internal growth and a series of technology and business acquisitions. Guy sits on the Boards of several medical device companies. He has a PhD from Georgetown University and a MBA.

  • Default avatar
    Vicki E. Farrar, Esq.
    Chief Executive Officer, Director and Co-founder

    Vicki’s experience as a VP in life science start-ups and as an attorney for 30 years in the medical device and pharmaceutical fields, specializing in world-wide IP strategy, is vital to her CEO role. Prior to her work at start-ups, Vicki was in private practice at Covington & Burling, of counsel at Irell & Manella and a partner at Morrison & Foerester.

  • Default avatar
    Donald D. Solomon, PhD.
    Chief Operating Officer and Co-founder

    Don has 30 years of healthcare experience, with a focus in vascular access technology. Most recently he was COO, CTO and Dir. of SHPI (OTC: SHPI), which was acquired by C.R. Bard. Prior, he was the Dir. of R&D at Johnson & Johnson Medical-Vascular Access. Don also spent 14 years at Becton Dickinson where he served as a Worldwide Dir. of R&D. He holds over 60 patents and has a PhD from Case Western Reserve and BS in Chemistry from Weber State.

  • Default avatar
    David Green
    Chief Financial Officer

    David has 17 years’ experience in operating and advisory roles. Most recently he was CFO of SJW Corp. (NYSE: SJW). He was also CFO of SHPI (OTC: SHPI) and instrumental in its sale to C.R. Bard. David was also an advisor to life science companies with Ernst & Young and Duff & Phelps. David received an MBA in finance from the University of Rochester and a BS in chemistry from the State University of New York. He is a registered CPA.

  • Default avatar
    Charity R. Williams, Esq.
    Chief Business Officer

    Charity has 14 years of experience in sales, marketing and business development roles. She was Dir. of Marketing at ZEVEX before its sales to Moog. Most recently, she was an Associate at Cooley where her practice focused on assisting life science companies. She also was a Sr. Associate at the University Venture Fund where she executed life science venture capital investments. She has a JD from the University of Utah and a BA in Business.

  • Default avatar
    Perry Borch
    Vice President of Sales

    Perry has more than 27 years of proven sales success in the healthcare industry. He spent 19 years with C.R. Bard, Inc. where his last role was the VP of Sales for Bard Peripheral Vascular. Since leaving Bard, Perry has held VP and General Management roles with a number of major medical device companies. His expertise is in developing and executing sales plans, strategies, and tactics that exceed desired results.

Advisors

  • Default avatar
    Mathew Romney, Kunzler Law Group
    Lawyer
    Unconfirmed
    Default avatar
    Larson & Rosenberger
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Aphelion Capital, Kickstart Seed Fund, University Venture Fund
    Unconfirmed
    Default avatar
    Salt Lake Angels, Palo Alto Life Science Angels, Olympus Angels
    Unconfirmed
    Default avatar
    Sand Hill Angels, Peterson Partners, Individuals (domestic & int'l)
    Unconfirmed